These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30378477)

  • 1. Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods.
    Avram S; Puia A; Udrea AM; Mihailescu D; Mernea M; Dinischiotu A; Oancea F; Stiens J
    Curr Med Chem; 2020; 27(1):78-98. PubMed ID: 30378477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Therapeutic Approaches to Alzheimer's Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools.
    Avram S; Mernea M; Limban C; Borcan F; Chifiriuc C
    Curr Neuropharmacol; 2020; 18(8):696-719. PubMed ID: 31885353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Cheminformatics-Molecular Docking Approach to Drug Discovery Against Viruses.
    Anwar MF; Khalid R; Hasanain A; Naeem S; Zarina S; Abidi SH; Ali S
    Infect Disord Drug Targets; 2020; 20(2):150-159. PubMed ID: 30345931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
    Abdolmaleki A; Ghasemi JB; Ghasemi F
    Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity.
    Udrea AM; Gradisteanu Pircalabioru G; Boboc AA; Mares C; Dinache A; Mernea M; Avram S
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Deficit in Neuropsychiatric Disorders through Monitoring of Arsenic and Its Derivatives as Well as Through Bioinformatics and Cheminformatics.
    Avram S; Udrea AM; Negrea A; Ciopec M; Duteanu N; Postolache C; Duda-Seiman C; Duda-Seiman D; Shaposhnikov S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cheminformatics Explorations of Natural Products.
    Prieto-Martínez FD; Norinder U; Medina-Franco JL
    Prog Chem Org Nat Prod; 2019; 110():1-35. PubMed ID: 31621009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalos Suite: New Cheminformatics Platform for Drug Discovery and Computational Toxicology.
    Varsou DD; Nikolakopoulos S; Tsoumanis A; Melagraki G; Afantitis A
    Methods Mol Biol; 2018; 1800():287-311. PubMed ID: 29934899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics and cheminformatics: where do the twain meet?
    Sukumar N; Krein M; Breneman CM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):311-9. PubMed ID: 18428084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an integrated cheminformatics-molecular docking approach for discovery for physicochemically similar analogs of fluoroquinolones as putative HCV inhibitors.
    Anwar MF; Khalid R; Hasanain A; Naeem S; Zarina S; Abidi SH; Ali S
    Comput Biol Chem; 2020 Feb; 84():107167. PubMed ID: 31855781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Strength-Weaknesses-Opportunities-Threats (SWOT) Analysis of Cheminformatics in Natural Product Research.
    Kirchweger B; Rollinger JM
    Prog Chem Org Nat Prod; 2019; 110():239-271. PubMed ID: 31621015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to cheminformatics.
    Wishart DS
    Curr Protoc Bioinformatics; 2007 Jun; Chapter 14():Unit 14.1. PubMed ID: 18428788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
    Zaka M; Abbasi BH; Durdagi S
    J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Peptide Natural Products as Lead Structures for Medicinal Use.
    Dang T; Süssmuth RD
    Acc Chem Res; 2017 Jul; 50(7):1566-1576. PubMed ID: 28650175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.
    Thomford NE; Senthebane DA; Rowe A; Munro D; Seele P; Maroyi A; Dzobo K
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-contained sequence representation: bridging the gap between bioinformatics and cheminformatics.
    Chen WL; Leland BA; Durant JL; Grier DL; Christie BD; Nourse JG; Taylor KT
    J Chem Inf Model; 2011 Sep; 51(9):2186-208. PubMed ID: 21800899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Cheminformatics Analysis of Structural Features Affecting the Binding Activity of Fullerene Derivatives.
    Fjodorova N; Novič M; Venko K; Rasulev B
    Nanomaterials (Basel); 2020 Jan; 10(1):. PubMed ID: 31906497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
    Bian Y; Feng Z; Yang P; Xie XQ
    AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacology in Drug Development: A Minireview of Current Technologies.
    Tan Z; Chaudhai R; Zhang S
    ChemMedChem; 2016 Jun; 11(12):1211-8. PubMed ID: 27154144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.